Catatonia After Liver Transplantation
- 28 August 2018
- journal article
- research article
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 23, 608-614
Abstract
BACKGROUND Central nervous system complications after transplantation occur in up to 40% of recipients and these complications are associated with increased length of hospital stay and mortality. Catatonia is a neuropsychiatric clinical syndrome which has been described in case reports and in a small case series as occurring in the immediate post-solid organ transplantation (SOT) period, and it has been attributed to calcineurin inhibitor neurotoxicity, psychological vulnerability, and depression. Among transplant recipients, the incidence of catatonia is unknown; it may be under diagnosed in part due to a broad differential diagnosis in the post-transplantation setting, which includes hypoactive delirium, non-convulsive status epilepticus, drug toxicity, conversion disorder, and volitional uncooperativeness. CASE REPORT We present 2 cases of catatonia diagnosed in liver allograft recipients. We also reviewed current literature for cases of catatonia among SOT recipients. We provide provisional evaluation and management strategies of recipients with clinical concern for catatonia. Catatonia generally occurs within the few first days after liver transplantation, and presents with staring, immobility, or mutism, but is also associated with other neurological and psychiatric symptoms. Catatonia can be successfully treated with intravenous lorazepam, and thus, modifying immunosuppressive regimens may be avoidable. Medications to treat catatonia are generally tapered over weeks to months, and psychiatric follow-up is indicated. The early post-liver transplantation period may be a state of relative deficiency in GABA (gamma-aminobutyric acid) signaling, predisposing liver transplant recipients in particular to post-transplantation catatonia. CONCLUSIONS Despite difficulties in establishing the diagnosis, catatonia after liver transplantation was rapidly responsive to intravenous lorazepam, indicating that changing immunosuppressants may be avoidable.Keywords
This publication has 28 references indexed in Scilit:
- GABAergic neurosteroids: The “endogenous benzodiazepines” of acute liver failureNeurochemistry International, 2012
- Catatonia as a manifestation of tacrolimus-induced neurotoxicity in organ transplant patients: a case seriesGeneral Hospital Psychiatry, 2012
- Extent of Reversibility of Hepatic Encephalopathy Following Liver TransplantationClinics in Liver Disease, 2012
- Catatonia after liver and kidney transplantationGeneral Hospital Psychiatry, 2009
- Catatonic mutism after liver transplant rapidly reversed with lorazepamGeneral Hospital Psychiatry, 2007
- Catatonia After Liver TransplantationPsychosomatics, 2006
- Postoperative Echolalia and Catatonia Responsive to Gamma Aminobutyric Acid Receptor Agonists in a Liver Transplant PatientAnesthesia & Analgesia, 2006
- What catatonia can tell us about “top-down modulation”: A neuropsychiatric hypothesisBehavioral and Brain Sciences, 2002
- Catatonia and Liver TransplantPsychosomatics, 2002
- Catatonia Responsive to Intravenous Lorazepam in a Patient With Cyclosporine Neurotoxicity and HypomagnesemiaPsychosomatics, 1993